Novartis Hits Teva With Another Lotrel Suit
Novartis International AG now has two patent suits pending against generics maker Teva Pharmaceuticals USA Inc. over the blockbuster hypertension drug Lotrel, lodging a new complaint after Teva submitted a bid...To view the full article, register now.
Already a subscriber? Click here to view full article